FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043965178> ?p ?o ?g. }

• W2043965178 abstract "Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors.The present study was performed on 11 patients with stable proteinuria who were diagnosed as AA amyloidosis secondary to rheumatological diseases confirmed by renal biopsies. The study had three consecutive stages (celecoxib 200 mg/day; indomethacin 100 mg/day; rofecoxib 25 mg/day.) Each was given for 4 weeks and a wash-out phase of 3 weeks was allowed between consecutive stages.Although the decrease of proteinuria in the celecoxib period was higher than in the rofecoxib and indomethacin periods, the difference was not statistically significant. No statistically significant differences were found between serum urea, creatinine, creatinine clearance and urinary sodium excretion.In this study, no differences were found between indomethacin and the two selective COX-2 inhibitors in respect to proteinuria and renal functions in 11 patients with renal amyloidosis secondary to rheumatological diseases with varying degrees of proteinuria. Routine doses of NSAIDs brought no additional benefit to the ACE inhibitor use in terms of proteinuria and renal functions. The use of selective COX-2 inhibitors should be limited to their anti-inflammatory and analgesic effects in this population." @default.
• W2043965178 created "2016-06-24" @default.
• W2043965178 creator A5025510476 @default.
• W2043965178 creator A5029451594 @default.
• W2043965178 creator A5031326633 @default.
• W2043965178 creator A5036151650 @default.
• W2043965178 creator A5051490867 @default.
• W2043965178 creator A5052025934 @default.
• W2043965178 creator A5077457262 @default.
• W2043965178 date "2006-06-01" @default.
• W2043965178 modified "2023-09-23" @default.
• W2043965178 title "Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis" @default.
• W2043965178 cites W1980242785 @default.
• W2043965178 cites W1995528018 @default.
• W2043965178 cites W2002109851 @default.
• W2043965178 cites W2018035901 @default.
• W2043965178 cites W2019746199 @default.
• W2043965178 cites W2025143124 @default.
• W2043965178 cites W2031556289 @default.
• W2043965178 cites W2035810126 @default.
• W2043965178 cites W2057685090 @default.
• W2043965178 cites W2060043267 @default.
• W2043965178 cites W2061937172 @default.
• W2043965178 cites W2065137976 @default.
• W2043965178 cites W2121766816 @default.
• W2043965178 cites W2135393211 @default.
• W2043965178 cites W2139776244 @default.
• W2043965178 cites W2152500325 @default.
• W2043965178 cites W2155820793 @default.
• W2043965178 cites W2157734027 @default.
• W2043965178 cites W2158131645 @default.
• W2043965178 cites W2163756514 @default.
• W2043965178 cites W2330496155 @default.
• W2043965178 doi "https://doi.org/10.1111/j.1440-1797.2006.00562.x" @default.
• W2043965178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16756637" @default.
• W2043965178 hasPublicationYear "2006" @default.
• W2043965178 type Work @default.
• W2043965178 sameAs 2043965178 @default.
• W2043965178 citedByCount "3" @default.
• W2043965178 crossrefType "journal-article" @default.
• W2043965178 hasAuthorship W2043965178A5025510476 @default.
• W2043965178 hasAuthorship W2043965178A5029451594 @default.
• W2043965178 hasAuthorship W2043965178A5031326633 @default.
• W2043965178 hasAuthorship W2043965178A5036151650 @default.
• W2043965178 hasAuthorship W2043965178A5051490867 @default.
• W2043965178 hasAuthorship W2043965178A5052025934 @default.
• W2043965178 hasAuthorship W2043965178A5077457262 @default.
• W2043965178 hasConcept C126322002 @default.
• W2043965178 hasConcept C126894567 @default.
• W2043965178 hasConcept C134018914 @default.
• W2043965178 hasConcept C159641895 @default.
• W2043965178 hasConcept C181199279 @default.
• W2043965178 hasConcept C185592680 @default.
• W2043965178 hasConcept C2776467144 @default.
• W2043965178 hasConcept C2778582115 @default.
• W2043965178 hasConcept C2779561371 @default.
• W2043965178 hasConcept C2779689624 @default.
• W2043965178 hasConcept C2779951007 @default.
• W2043965178 hasConcept C2780091579 @default.
• W2043965178 hasConcept C2780306776 @default.
• W2043965178 hasConcept C2908647359 @default.
• W2043965178 hasConcept C55493867 @default.
• W2043965178 hasConcept C71924100 @default.
• W2043965178 hasConcept C90924648 @default.
• W2043965178 hasConcept C98274493 @default.
• W2043965178 hasConcept C99454951 @default.
• W2043965178 hasConceptScore W2043965178C126322002 @default.
• W2043965178 hasConceptScore W2043965178C126894567 @default.
• W2043965178 hasConceptScore W2043965178C134018914 @default.
• W2043965178 hasConceptScore W2043965178C159641895 @default.
• W2043965178 hasConceptScore W2043965178C181199279 @default.
• W2043965178 hasConceptScore W2043965178C185592680 @default.
• W2043965178 hasConceptScore W2043965178C2776467144 @default.
• W2043965178 hasConceptScore W2043965178C2778582115 @default.
• W2043965178 hasConceptScore W2043965178C2779561371 @default.
• W2043965178 hasConceptScore W2043965178C2779689624 @default.
• W2043965178 hasConceptScore W2043965178C2779951007 @default.
• W2043965178 hasConceptScore W2043965178C2780091579 @default.
• W2043965178 hasConceptScore W2043965178C2780306776 @default.
• W2043965178 hasConceptScore W2043965178C2908647359 @default.
• W2043965178 hasConceptScore W2043965178C55493867 @default.
• W2043965178 hasConceptScore W2043965178C71924100 @default.
• W2043965178 hasConceptScore W2043965178C90924648 @default.
• W2043965178 hasConceptScore W2043965178C98274493 @default.
• W2043965178 hasConceptScore W2043965178C99454951 @default.
• W2043965178 hasLocation W20439651781 @default.
• W2043965178 hasLocation W20439651782 @default.
• W2043965178 hasOpenAccess W2043965178 @default.
• W2043965178 hasPrimaryLocation W20439651781 @default.
• W2043965178 hasRelatedWork W1990756964 @default.
• W2043965178 hasRelatedWork W2031694281 @default.
• W2043965178 hasRelatedWork W2053833211 @default.
• W2043965178 hasRelatedWork W2084602324 @default.
• W2043965178 hasRelatedWork W2106174594 @default.
• W2043965178 hasRelatedWork W2916219914 @default.
• W2043965178 hasRelatedWork W4235119269 @default.
• W2043965178 hasRelatedWork W4291014994 @default.
• W2043965178 hasRelatedWork W593504957 @default.
• W2043965178 hasRelatedWork W2088864129 @default.
• W2043965178 isParatext "false" @default.

• next